MUMBAI, India, Jan. 23 -- Intellectual Property India has published a patent application (202511123911 A) filed by Noida Institute Of Engineering & Technology, Greater Noida, Uttar Pradesh, on Dec. 9, 2025, for 'a method for evaluation of verbena officinalis for treatment of dexamethasone induced diabetes mellitus.'
Inventor(s) include Dr Avijit Mazumder; Dr Saumya Das; Sanskriti; Bhavani Pentela; Dr Rakhi Mishra; and Dr Sushma Verma.
The application for the patent was published on Jan. 23, under issue no. 04/2026.
According to the abstract released by the Intellectual Property India: "Disclosed herein is a method for evaluation of verbena officinalis for treatment of dexamethasone-induced diabetes mellitus (100) comprises collecting and authenticating leaves of verbena officinalis (102). The method also includes preparing a methanolic extract (104. The method also includes performing preliminary phytochemical screening of the extract (106) to identify bioactive constituents. The method also includes inducing diabetes mellitus by administration of dexamethasone (108). The method also includes administering the methanolic extract of verbena officinalis (110). The method also includes evaluating the antidiabetic effect and its complication-mitigating potential of the extract (112) by assessing parameters. The method also includes comparing the results of the verbena officinalis treated groups (114) with a standard antidiabetic treatment to determine therapeutic efficacy."
Disclaimer: Curated by HT Syndication.
